MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from exercises
of stock options
$1,674K
Proceeds from issuance of
common stock under...
$465K
Proceeds from exercises
of warrants, net of...
$130K
Net cash provided by
financing activities
$2,212K
Canceled cashflow
$57K
Net (decrease)
increase in cash and cash...
-$12,416K
Canceled cashflow
$2,212K
Stock-based compensation
$1,912K
Accrued liabilities
$1,832K
Non-cash lease expense
$308K
Write-off of deferred
issuance costs
$281K
Amortization of intangible
assets
$167K
Depreciation
$88K
Other
-$62K
Accounts receivable
-$55K
Other non-current
assets
-$3K
Payment of deferred
issuance costs in...
$57K
Net cash used in
operating activities
-$14,595K
Canceled cashflow
$4,708K
Net cash used in
investing activities
-$33K
Net loss
-$18,581K
Lease liabilities,
net
-$375K
Accounts payable
-$148K
Prepaid expenses and
other current assets
$129K
Inventory
$70K
Purchases of property and
equipment
$33K
Back
Back
Cash Flow
PULSE BIOSCIENCES, INC. (PLSE)
PULSE BIOSCIENCES, INC. (PLSE)
source: myfinsight.com